Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
With the reigniting of the White House’s Cancer Moonshot Initiative, the ABTA recently joined the Brain Cancers Forum in Washington, D.C., to discuss opportunities in discovering treatments for brain cancers, including GBM.
**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
**Sponsored Content** Meet one neurosurgeon who hopes to transform brain tumor care by bringing state-of-the-art technology to his homeland of Puerto Rico.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
**Sponsored Content**
For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
As we welcome 2023, it’s a time to embrace the new year and new ways to get involved and make an impact in the brain tumor community.
Always free for patients & caregivers
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
800+ children & adults are diagnosed with a brain tumor every single day.
